V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009920 | 310005461 | 0 | 91 | Palliative (P) | 2014-06-09 | 2014-06-10 | BEAM + Alemtuzumab Allo SCT | 02 | N | 310003259 | TRASTUZUMAB |
| 310009921 | 310005462 | 1.76 | 56.7 | Palliative (P) | null | 2019-01-22 | LENALIDOMIDE | N | N | 310003401 | IMATINIB |
| 310009922 | 310011848 | 1.76 | 72 | Curative (C) | 2019-01-28 | 2019-01-29 | ALL UKALL2011 TRIAL | N | N | 310003549 | EOX |
| 310009923 | 310005465 | 1.75 | 68.9 | Adjuvant (A) | 2016-01-06 | 2016-01-06 | Thalidomide 100mg | 2 | null | 310003649 | SUNITINIB |
| 310009924 | 310005466 | 1.75 | 78 | Palliative (P) | 2017-06-08 | 2017-06-11 | DABRAFENIB + TRAMETINIB | N | N | 310003672 | IVE-R |
| 310009925 | 310005470 | 1.71 | 99.8 | Palliative (P) | 2015-06-08 | 2015-06-08 | ECF | null | null | 310003701 | CHOEP |
| 310009926 | 310005471 | 1.63 | 50 | Palliative (P) | 2017-04-07 | 2017-04-14 | Atezolizumab | Y | N | 310003732 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310009927 | 310005473 | 1.53 | null | Palliative (P) | 2015-12-10 | 2015-12-12 | Hydroxycarbamide | N | N | 310003753 | CHOEP |
| 310009928 | 310005474 | 1.71 | 88.2 | Palliative (P) | 2018-06-05 | 2018-06-06 | ECX | 02 | N | 310003761 | CETUXIMAB |
| 310009929 | 310005478 | 1.85 | null | Palliative (P) | 2015-01-16 | 2015-06-30 | DOXORUBICIN | N | N | 310003808 | IMATINIB |
| 310009930 | 310008417 | 1.74 | 46.1 | Palliative (P) | 2015-03-21 | 2015-09-15 | Gemcitabine + Treosulfan (iv) | N | Y | 310003812 | METHOTREXATE |
| 310009931 | 310005482 | 1.86 | null | Palliative (P) | 2014-05-07 | 2014-07-01 | DHAP | 02 | null | 310004066 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 310009932 | 310005483 | 1.78 | 77.8 | Palliative (P) | 2015-03-17 | 2016-09-20 | Cyclophosphamide+Fludara+TBI Allo | N | N | 310004066 | CAPECITABINE + CARBOPLATIN |
| 310009933 | 310011330 | 1.73 | 106 | Curative (C) | 2018-04-05 | 2018-04-05 | Methotrexate Intermed dose (1g/m2) | N | N | 310004863 | GEMCITABINE + OXALIPLATIN |
| 310009934 | 310011330 | 0 | 48.6 | Curative (C) | 2015-03-22 | 2015-06-18 | Hydroxycarbamide | N | N | 310004863 | GEMCITABINE + TREOSULPHAN |
| 310009935 | 310005484 | null | null | Neo-adjuvant (N) | 2017-09-12 | 2017-09-17 | Topotecan (intravenous) | N | null | 310005210 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 310009936 | 310011331 | 1.83 | 68.7 | Palliative (P) | 2014-10-31 | 2014-11-01 | FLUOROURACIL + MITOMYCIN | 02 | N | 310005670 | CAPECITABINE + CISPLATIN |
| 310009937 | 310008422 | 1.7 | 94.3 | Curative (C) | 2014-01-28 | 2014-01-28 | CARBOPLATIN + VINORELBINE | N | null | 310005975 | METHOTREXATE HIGH DOSE |
| 310009938 | 310005490 | 1.57 | null | Palliative (P) | 2013-09-24 | 2015-06-06 | Cytarabine HD + Methotrexate HD | N | null | 310005975 | VIDE |
| 310009939 | 310005491 | 1.64 | null | null | 2016-06-16 | 2016-10-10 | CAPECITABINE + OXALIPLATIN | N | N | 310006343 | OCTOPUS TRIAL |
| 310009940 | 310005492 | 1.62 | 66 | Palliative (P) | 2014-07-27 | 2014-07-27 | PEG INTERFERON | N | N | 310006677 | CYTARABINE HD + METHOTREXATE HD |
| 310009941 | 310005493 | 1.82 | null | Palliative (P) | 2016-01-01 | 2016-01-01 | BCG Intravesical | 02 | null | 310006698 | DACARBAZINE |
| 310009942 | 310005496 | 1.6 | 79 | Adjuvant (A) | 2019-01-01 | 2019-01-07 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | 02 | N | 310006958 | VINCRISTINE |
| 310009943 | 310009994 | 1.95 | 64 | Palliative (P) | 2017-08-29 | 2017-09-02 | DABRAFENIB + TRAMETINIB | N | N | 310007069 | ECHELON-2 TRIAL |
| 310009944 | 310005497 | 1.69 | 0 | Palliative (P) | 2016-01-17 | 2016-01-19 | Niraparib | N | N | 310007286 | BEVACIZUMAB + CARBO |
| 310009945 | 310008431 | 1.74 | null | Curative (C) | 2015-12-09 | 2016-02-12 | Capecitabine + Oxaliplatin 21day | 02 | N | 310007470 | MELPHALAN |
| 310009946 | 310010851 | 1.84 | null | Neo-adjuvant (N) | 2014-01-06 | 2014-01-07 | Ifosfamide | Y | N | 310007558 | CYTARABINE + METHOTREXATE |
| 310009947 | 310005504 | 1.58 | 64.1 | Adjuvant (A) | 2016-11-10 | 2016-11-12 | Chlorambucil | 2 | N | 310007558 | BCG |
| 310009948 | 310005508 | 1.85 | 71.6 | Palliative (P) | 2018-05-30 | 2018-07-11 | Triple / Double Intrathecal Therapy | null | null | 310009263 | METHOTREXATE |
| 310009949 | 310005509 | 1.69 | 96 | Curative (C) | 2015-07-31 | 2015-08-07 | Alemtuzumab | N | N | 310009636 | BEP |
| 310009950 | 310005510 | 1.59 | 63.4 | Curative (C) | 2017-04-10 | 2017-05-06 | STS Rhabdo RMS 2005 Vin Cyclo | 2 | N | 310010574 | AZACITIDINE |
| 310009951 | 310008439 | null | 96 | Palliative (P) | null | 2018-11-05 | Retinoblastoma JOE | N | null | 310010646 | CAPECITABINE + CARBOPLATIN |
| 310009952 | 310005513 | null | null | Curative (C) | 2017-08-22 | 2017-08-27 | Hydroxycarbamide | N | N | 310010718 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310009953 | 310010002 | 1.84 | 118 | Palliative (P) | 2015-07-29 | 2015-09-17 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 310011142 | OXALIPLATIN + MDG |
| 310009954 | 310005518 | 1.66 | 23.6 | Palliative (P) | 2015-09-12 | 2016-01-02 | Cisplatin + Fluorouracil + RT 5day | Y | null | 310011231 | MITOMYCIN |
| 310009955 | 310008443 | null | 0 | Palliative (P) | 2015-09-17 | 2017-03-06 | Capecitabine + Cisplatin | null | null | 310011253 | ALEMTUZUMAB |
| 310009956 | 310005524 | null | 55.5 | Neo-adjuvant (N) | 2018-05-01 | 2018-05-01 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | Y | 310011812 | BCG |
| 310009957 | 310005525 | 1.77 | null | c | 2018-03-27 | 2019-07-02 | BCG Intravesical | null | null | 310012201 | CAPECITABINE + OXALIPLATIN |
| 310009958 | 310005526 | 1.56 | 65 | Disease modification (D) | 2017-03-06 | 2017-03-06 | Capecitabine | 02 | N | 310012353 | CARBOPLATIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + PACLITAXEL |
| 310009959 | 310005527 | 1.72 | null | Neo-adjuvant (N) | 2019-06-10 | 2019-06-10 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 310012726 | CAPECITABINE + CARBOPLATIN |
| 310009960 | 310005528 | 1.73 | 47.2 | Palliative (P) | 2017-07-25 | 2017-11-13 | Fludarabine + Melphalan RIC Allo | N | N | 310012966 | CAPECITABINE |
| 310009961 | 310005531 | 1.73 | 52 | Curative (C) | 2017-02-20 | 2017-07-26 | CAV | N | N | 310013066 | PEG INTERFERON |
| 310009962 | 310005534 | 1.79 | 77.7 | Not known (9) | 2014-06-02 | 2014-06-23 | Cape+Cisplatin+Trastuzumab Main | 02 | N | 310013139 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 310009963 | 310005536 | 1.79 | 85.6 | Palliative (P) | 2016-10-26 | 2016-12-30 | SelPac Trial | N | N | 310013310 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310009964 | 310008453 | null | null | Palliative (P) | 2017-11-17 | 2017-12-07 | BEP 5 Day | null | null | 310013706 | CETUXIMAB |
| 310009965 | 310005544 | 1.64 | null | Palliative (P) | 2017-11-23 | 2017-09-23 | Trastuzumab Subcutaneous | null | null | 310015036 | RMS 2005 TRIAL |
| 310009966 | 310005545 | null | 12.4 | Disease modification (D) | null | 2015-07-06 | Capecitabine | 02 | null | 310015053 | OXALIPLATIN + MDG |
| 310009967 | 310005546 | 1.67 | 78.6 | Curative (C) | 2014-07-10 | 2014-07-10 | Temozolomide 200mg/m2 | 02 | N | 310015515 | ALEMTUZUMAB |
| 310009968 | 310008458 | null | null | Palliative (P) | 2017-03-26 | 2017-08-06 | Dacarbazine | N | N | 310015715 | EOX |
| 310009969 | 310005549 | null | 63.9 | Palliative (P) | 2016-05-08 | 2016-05-29 | STS Rhabdo RMS 2005 Vin Cyclo | N | null | 310015779 | CERITINIB |